Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP)

During the Trading Day
8.43 +0.28 / +3.44%
As of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
8.43 -0.001 / -0.01%
Volume: 388.00
Health Technology
Pharmaceuticals: Other

Company Description

Tonix Pharmaceuticals Holding Corp. is a pharmaceutical company. It is engaged in developing and manufacturing new pharmaceutical products that are used in central nervous system drugs in large and growing markets. It products include TNX-102 SL and TNX-201. Tonix Pharmaceuticals Holding was founded by Seth Lederman and Donald W. Landry on November 16, 2007 and is headquartered in New York, NY.

Contact Information

Tonix Pharmaceuticals Holding Corp.
509 Madison Avenue
New York New York 10022
P:(212) 980-9155
Investor Relations:



Individual stakeholders5.62%
Mutual fund holders5.56%
Other institutional38.47%

Top Executives

Seth LedermanChairman, President & Chief Executive Officer
Leland J. GershellChief Financial Officer & Treasurer
Gregory M. SullivanChief Medical Officer
Bruce L. DaughertySecretary, Chief Scientific Officer & Controller
Jessica E. EdgarSenior Vice President-Finance